Topic summary

When a dose reduction is the correct response to a side effect

Practice › Dosing & titration dose reduction tirzepatide titration missed dose semaglutide Solved

This is a generated summary. It shows the 6 most-liked posts from a topic of 43, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.

j.solbergTL2 Moderator7 Mar 2026#4

Two things before anyone answers the substance.

First, the context in the first post is clear and specific. Second, the question is framed so that an answer can actually address it. Both are the norm here and both matter more than they sound.

27 likes 5mo

g.danquahTL2 Moderator Solution18 Mar 2026#6

Makinen, post #3: Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been studied clinically. One mg of semaglutide is not equivalent to one mg of something else in any meaningful sense. Go to post

The four-week escalation interval is a convention from the pivotal trials, not a pharmacological constant. The pharmacological argument is that with a week-long half-life, four weeks approaches steady state and you can assess the dose fairly. That is an argument for not going faster. It is not an argument against going slower.

11 likes in reply to #3 4mo

LJankowiakTL3Regular28 Apr 2026#16

Buchholz, post #7: How the published trials escalated: they used specific step sizes and intervals. The STEP programme used a particular cadence; the SURPASS and SURMOUNT programmes used slightly different ones. Reading them side by side shows the variation is real but small. Go to post

The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The reasoning is pharmacological — e.g., "I will split the difference between steps" — but it is reasoning from theory, not from evidence.

31 likes in reply to #7 3mo

n.oseiTL2 Moderator27 May 2026#24

titration_diary, post #5: post #4 answers the question as asked. The question underneath it is different. Micro-titration: the concept of increments smaller than the labelled steps. It has no evidence base from trials but is described by some people. The downside is that very small increments are hard to measure accurately with a syringe. Go to post

Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose. Escalating before steady state means escalating on incomplete information about the dose you are on.

28 likes in reply to #5 2mo

l.wikstromTL2 Moderator13 Jun 2026#29

For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.

29 likes 1mo

sterile_tableTL3Regular2 Jul 2026#35

n.osei, post #24: Steady state means the plasma concentration is stable from dose to dose. That happens around 4 to 5 half-lives. Before that, the concentration is rising with each dose. Escalating before steady state means escalating on incomplete information about the dose you are on. Go to post

Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The trials escalated to a target and then held that. What happens if you stay at an intermediate dose for years is not formally studied and extrapolation is the best available reasoning.

27 likes in reply to #24 25d

Read the full topic (43 posts)

Suggested topics

Topic	Participants	Replies	Views	Activity
Why "dose equivalence" between different incretin analogues is a weak concept Practice › Dosing & titration tirzepatide dose reduction titration semaglutide Solved Why "dose equivalence" between different incretin analogues is a weak concept I have a specific reason for asking rather than idle curiosity, and the context is below. I have read the maintained page on this…	+124	133	11k	5mo
How the published trials escalated, tabulated side by side — does this still hold? Practice › Dosing & titration dose reduction tirzepatide missed dose Solved Asking directly, because I could not find a straight answer: How the published trials escalated, tabulated side by side — does this still hold? A question about technique rather than about dose. I have been…		2	8.9k	9mo
How the published trials escalated, tabulated side by side Practice › Dosing & titration worked example semaglutide titration dose reduction Solved Closed The question in the title: How the published trials escalated, tabulated side by side I will give what I have already checked below so nobody repeats it. A question about technique rather than about dose. I…	+4	8	4.2k	5mo
The arithmetic of an intermediate dose between two label steps Practice › Dosing & titration dose reduction semaglutide missed dose On the subject in the title: The arithmetic of an intermediate dose between two label steps Working notes rather than a conclusion. I have read the maintained page on this and I still have a gap, so I am…		2	136	2mo
About the Dosing & titration category Practice › Dosing & titration titration dose reduction worked example Pinned Wiki Schedules, escalation intervals, dose reductions, and the arithmetic that connects a vial to a syringe mark. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is…		4	350	4mo

Related topics — sharing the tags dose reduction, tirzepatide, titration

Topic	Participants	Replies	Views	Activity
Five questions in one post gets you one answer — how to split them Start Here › How to Ask guidelines site feedback worked example Closed On the subject in the title: Five questions in one post gets you one answer — how to split them Working notes rather than a conclusion. Question in the title. Context below, and I have tried to include the…	+84	90	1k	2mo
Second pass at: Albumin binding and how it produces a long half-life Pharmacology › Pharmacokinetics missed dose worked example semaglutide Posting this under the heading it deserves: Second pass at: Albumin binding and how it produces a long half-life Everything below is what sits behind that. I would like to understand what this number means…	+7	11	31k	17mo
Feature request: should a dose-equivalence tool exist at all? Data & Tools › Calculators site feedback worked example concentration maths syringe units Closed Feature request: should a dose-equivalence tool exist at all? — that is the question, and I have not found it answered plainly anywhere I have looked. Posting the method first, because I know what the first…	+21	25	4.8k	18mo
Follow-up: Dead volume across syringe and needle combinations Devices › Syringes & needles syringe units worked example subcutaneous injection dead volume Solved Dead volume across syringe and needle combinations — setting out what I have, and where I think it stops being reliable. Practical question with the units stated, because I have seen how quickly these go…	+81	98	22k	18mo
Albumin binding and how it produces a long half-life Pharmacology › Pharmacokinetics semaglutide liraglutide worked example tirzepatide Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I repeat it anywhere. A…	+38	44	6.6k	14mo